EFFETS DE L'HORMONE PARATHYROIDIENNE ET DE LA CALCITONINE SUR L'EXCRETION RENALE DU 3',5'-MONOPHOSPHATE D'ADENOSINE ET DES ELECTROLYTESCZEKALSKI S.1976; ENDOKRYNOL. POLSKA; POLSKA; DA. 1976; VOL. 27; NO 2; PP. 219-225; ABS. RUSSE ANGL.; BIBL. 11 REF.Article

How to diagnose and how to interpret microalbuminuria in the diabetic patientCZEKALSKI, S.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 8, pp 1509-1511, issn 0931-0509Conference Paper

TAUX DE L'INSULINE ET DE L'HORMONE DE CROISSANCE PLASMATIQUES AU COURS DE L'HEMODIALYSE CHEZ DES MALADES ATTEINTS DE L'INSUFFISANCE RENALE CHRONIQUECZEKALSKI S; CZARNECKI R; KOSOWICZ J et al.1972; POLSKIE ARCH. MED. WEWNETR.; POLSKA; DA. 1972; VOL. 48; NO 6; PP. 569-576; ABS. RUSSE ANGL.; BIBL. 14 REF.Article

TAUX PLASMATIQUE ET EXCRETION URINAIRE DE L'ADENOSINE-3',5' MONOPHOSPHATE (AMPC) CHEZ DES SUJETS NORMAUXCZEKALSKI S; EDER M; GRYCZYNSKA M et al.1975; ENDOKRYNOL. POLSKA; POLSKA; DA. 1975; VOL. 26; NO 5; PP. 517-524; ABS. RUSSE ANGL.; BIBL. 14 REF.Article

SERUM REVERSE TRIIODOTHYRONINE (3,3',5'-L-TRIIODOTHYRONINE) IN CHRONIC RENAL FAILUREKOSOWICZ J; MALCZEWSKA B; CZEKALSKI S et al.1980; NEPHRON; CHE; DA. 1980; VOL. 26; NO 2; PP. 85-89; BIBL. 14 REF.Article

DOSAGE RADIOIMMUNOLOGIQUE DE L'ACTHKOSOWICZ J; CZEKALSKI S; KOZLOWSKI W et al.1972; ENDOKRYNOL. POLSKA; POLSKA; DA. 1972; VOL. 23; NO 4; PP. 309-319; ABS. RUSSE ANGL.; BIBL. 12 REF.Article

LA VIBRAMYCINE DANS LE TRAITEMENT DE LA PYELONEPHRITE CHIMIQUECZEKALSKI S; KRZYMANSKI M; ZYCH J et al.1972; POLSKI TYGODN. LEK.; POLSKA; DA. 1972; VOL. 27; NO 39; PP. 1523-1525; ABS. RUSSE ANGL.; BIBL. 7REF.Serial Issue

THE ROLE OF CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE (CAMP) IN THE MECHANISM OF ACTION OF TRICYCLIC ANTIDEPRESSANTS.CHODERA A; BOBKIEWICZ T; CZEKALSKI S et al.1977; ARCH. IMMUNOL. THERAP. EXPER.; POLOGNE; DA. 1977; VOL. 25; NO 2; PP. 163-168; BIBL. 35 REF.Article

COMPARISON OF SOME CIRCULATING PITUITARY, THYROID, AND GONADAL HORMONE LEVELS IN NONDIALYZED AND DIALYZED MALES WITH CHRONIC RENAL FAILURECZEKALSKI S; MALCZEWSKA B; SOBIESZCZYK S et al.1981; DIAL. TRANSPLANT.; ISSN 0090-2934; USA; DA. 1981; VOL. 10; NO 5; PP. 438-443; 4 P.; BIBL. 11 REF.Article

Effect of atropine on plasma atrial natriuretic peptide concentration in healthy subjectsCZEKALSKI, S; WIDECKA, K; GOZDZIK, J et al.Annales de biologie clinique (Paris). 1990, Vol 48, Num 4, pp 232-234, issn 0003-3898Article

Role of cardiac parasympathetic dysfunction in atrial natriuretic peptide response to volume changes in patients with chronic renal failurePRUSZCZYNSKI, W; VIRON, B; CZEKALSKI, S et al.Mineral and electrolyte metabolism. 1987, Vol 13, Num 5, pp 333-339, issn 0378-0392Article

Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrationsCHANSEL, D; BADRE, L; CZEKALSKI, S et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 265, Num 3, pp 1534-1543, issn 0022-3565Article

Exaggerated natriuresis induced by sodium chloride infusion in essential hypertension is accompanied by an exaggerated urinary 35 guanosine monophosphate excretionWIDECKA, K; CELIBAŁA, R; GOZDZIK, J et al.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, Num 8, pp 711-715, issn 0931-0509Conference Paper

Atrial natriuretic peptide in diabetic patients with microangiopathyDUSSAULE, J. C; GRIMALDI, A; CZEKALSKI, S et al.Hormone and metabolic research. 1988, Vol 20, Num 9, pp 592-594, issn 0018-5043, 3 p.Article

Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy: effect of atrial fibrillationDUSSAULE, J.-C; VAHANIAN, A; MICHEL, P.-L et al.Circulation (New York, N.Y.). 1988, Vol 78, Num 2, pp 276-285, issn 0009-7322Article

Hip geometry, bone mineral distribution, and bone strength in European men and women : The EPOS studyCRABTREE, N; LUNT, M; FALCH, J. A et al.Bone (New York, NY). 2000, Vol 27, Num 1, pp 151-159, issn 8756-3282Article